AVIS: The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults
Study Details
Study Description
Brief Summary
Type 2 diabetes is more common among African Americans than Caucasians. African Americans are also at a higher risk for lower levels of vitamin D compared to other ethnic groups. The investigators don't yet know if there is a connection between not having enough vitamin D and type 2 diabetes in African Americans. Researchers have found that the less vitamin D Caucasians had the higher the chance they would have type 2 diabetes but it is less clear if this is the case for African Americans. The investigators want to better understand how vitamin D status and diabetes risk are linked in African Americans. Also, the investigators want to see if supplementation with vitamin D will improve your blood pressure, blood sugar, & insulin. All of these are in some way related to diabetes. The investigators want to measure changes in blood sugar & blood pressure in people who do not have diabetes with the hope of learning new information to help treat those that do have diabetes.
The investigators hypothesize that vitamin D status is related to diabetes risk measured by hemoglobin A1c (a test of glucose level over time), fasting glucose and insulin in non-diabetic African American adults and that body weight status may affect vitamin D status in response to vitamin D supplements compared to placebo.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Participants will be randomly assigned to receive either a 60,000 IU vitamin D3 supplement every four weeks or an inactive placebo. All investigators and the participants will be blinded to the assignment group of each participant until all testing is completed.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Vitamin D3 supplement 60,000 IU vitamin D3 oral supplement provided every four weeks at weeks 0, 4, 8, and 12 in the form of one 50,000 and two 5,000 IU vitamin D3 supplements in gelcap form. |
Dietary Supplement: vitamin D3, cholecalciferol
1 gelcap of 50,000 IU vitamin D3 plus 2 gelcaps of 5,000 IU vitamin D3 each; a total of 60,000 IU vitamin D3 dosed four weeks apart at weeks 0, 4, 8, and 12 of the 16 week study.
|
Placebo Comparator: Sugar Pill Inactive placebo tablets identical in appearance to the active comparator provided every four weeks at weeks 0,4,8,and 12. |
Dietary Supplement: Inactive comparator
The inactive comparator dose provided was identical in appearance to the active comparator but contained no vitamin D3
|
Outcome Measures
Primary Outcome Measures
- Fasting glucose level before, mid-way through, and after the vitamin D3 supplement or placebo trial. [16 weeks]
Secondary Outcome Measures
- Serum 25-OH D levels in response to vitamin D3 supplement or placebo across a range of adiposity [16 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
African American by self-report
-
In good health
Exclusion Criteria:
-
Diagnosis of diabetes
-
Health problems/medication affecting calcium and/or vitamin D metabolism
-
Current use of vitamin/mineral/herbal/nutritional supplements
-
Inability to swallow pills
-
Pregnancy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Medical College of Georgia | Augusta | Georgia | United States | 30912 |
Sponsors and Collaborators
- Augusta University
Investigators
- Study Director: Yanbin Dong, MD, PhD, Augusta University
Study Documents (Full-Text)
None provided.More Information
Publications
- Liu E, Meigs JB, Pittas AG, Economos CD, McKeown NM, Booth SL, Jacques PF. Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. Am J Clin Nutr. 2010 Jun;91(6):1627-33. doi: 10.3945/ajcn.2009.28441. Epub 2010 Apr 14.
- Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, Booth SL, Jacques PF. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 2009 Feb;139(2):329-34. doi: 10.3945/jn.108.093831. Epub 2008 Dec 23.
- Pittas AG, Dawson-Hughes B. Vitamin D and diabetes. J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):425-9. doi: 10.1016/j.jsbmb.2010.03.042. Epub 2010 Mar 18. Review.
- Voidonikola PT, Stamatelopoulos KS, Alevizaki M, Kollias GE, Zakopoulos NA, Lekakis JP, Anastasiou E, Theodorakis MJ, Pittas AG, Papamichael CM. The association between glycemia and endothelial function in nondiabetic individuals: the importance of body weight. Obesity (Silver Spring). 2008 Dec;16(12):2658-62. doi: 10.1038/oby.2008.431. Epub 2008 Oct 9.
- 0910091